Latest 20-F annual reports

Grab Holdings Limited reported its first net profit of $200 million in 2025, driven by robust growth in deliveries, mobility, and financial services across Southeast Asia.

ArcelorMittal reported a significant increase in net income and EPS for 2025, driven by strategic acquisitions and improved trade protection, despite a slight dip in overall sales.

GSK plc delivered robust financial performance in 2025 with significant sales and profit growth, driven by Specialty Medicines and key product approvals, alongside a smooth CEO transition and strategic pipeline investments.

BP delivered record operational reliability and significant project milestones in 2025, while navigating a strategic portfolio reset and leadership transition.

Fidelis Insurance Holdings Limited reported significant growth in gross premiums written and improved underwriting profitability in 2025, alongside a planned rebranding to Pelagos Insurance Capital Limited.

Wix.com Ltd. updated its 2013 Incentive Compensation Plan and reported robust 2025 financial results, including significant revenue growth and overachievement of free cash flow targets, alongside strategic acquisitions and a new share repurchase program.

Ardagh Metal Packaging S.A. reported a significant increase in revenue and profit for 2025, driven by higher input cost pass-through and favorable volume/mix effects, alongside a comprehensive debt recapitalization.

Stratasys Ltd. reported a 3.7% revenue decrease in 2025, alongside a reduced net loss and increased cash reserves following a strategic restructuring and a $120 million PIPE investment.

Nokia reports a 3% increase in net sales to EUR 19.89 billion in 2025, driven by the Infinera acquisition, despite a 55% drop in operating profit to EUR 885 million.

Evaxion A/S significantly reduced net losses and boosted cash reserves in 2025, driven by a landmark licensing agreement with MSD for its AI-designed vaccine candidate EVX-B3 and promising clinical data for EVX-01.

Linear Minerals Corp. filed an amendment to its Annual Report on Form 20-F for the fiscal year ended March 31, 2025, primarily to correct Section 906 certifications.

MediWound Ltd. reported a net loss of $23.9 million for 2025, a decrease from $30.2 million in 2024, as it continues significant investments in R&D and manufacturing expansion for NexoBrid and EscharEx.

HUTCHMED (China) Limited reported a significant increase in net income to $456.9 million in 2025, primarily driven by a $415.8 million net gain from the partial divestment of Shanghai Hutchison Pharmaceuticals, despite a decline in consolidated revenue.

Immatics N.V. reports significant progress in its PRAME-directed immunotherapy pipeline, including advancing lead cell therapy anzu-cel into Phase 3, alongside a recent $107.2 million public offering.

GH Research PLC announced positive clinical trial results for its mebufotenin product candidates, GH001 and GH002, and the lifting of a clinical hold on its GH001 IND by the FDA.

Caesarstone Ltd. reported a significant net loss of $137.5 million in 2025, alongside declining revenues and escalating legal expenses from silicosis claims, as it navigates major operational restructuring and market challenges.

Silver North Resources reported a significantly reduced net loss and a strengthened working capital position for fiscal year 2025, driven by successful capital raises and active exploration programs.

Costamare Inc. reports a net income of $369 million for 2025, driven by its containership fleet and expanding Neptune Maritime Leasing business, following the spin-off of its dry bulk operations.

Innoviz Technologies announced a significant increase in revenue and gross profit for 2025, driven by NRE sales and new product launches, while continuing to reduce net losses.

Oculis Holding AG reports an upsized loan facility of up to CHF 75 million and significant progress in its clinical pipeline, including expected topline results for OCS-01 and Licaminlimab in 2026.

Integrated Media Technology Limited filed an amendment to its 2025 annual report to clarify its corporate governance practices as a foreign private issuer under NASDAQ rules.

Nexxen International Ltd. reports a slight revenue dip in 2025, driven by a strategic shift away from non-programmatic business, while focusing on CTV and Video growth and expanding its V partnership.

Safe Bulkers, Inc. reported a significant decrease in net income and revenues for the fiscal year ended December 31, 2025, while continuing its fleet renewal and environmental upgrade strategy.

Anheuser-Busch InBev reports a 0.8% revenue decrease to $59.3 billion in 2025, driven by volume declines in key markets, while digital platforms and premiumization initiatives show strong growth.

Paysafe Limited reported a net loss of $182.5 million for fiscal year 2025, a significant decline from the prior year's net income, despite an increase in total payment volume and strategic divestiture.

Viking Holdings Ltd announced robust financial and operational growth for 2025, driven by increased capacity, higher occupancy, and strategic fleet expansion across its river, ocean, and expedition cruise segments.

SOPHiA GENETICS SA reported a 19% increase in revenue to $77.3 million for 2025, driven by platform adoption and analysis volume, while navigating an ongoing patent infringement lawsuit and increasing net losses.

On Holding AG achieved significant net sales growth of 30% in fiscal year 2025, driven by strong demand across all channels and regions, despite a 15.9% decrease in net income.

Magnitude International Ltd. reported a significant decrease in revenue and net profit for the fiscal year ended April 30, 2025, alongside updates on corporate governance and cybersecurity risk management.

eToro Group Ltd. announced significant financial growth in 2025, including a 12% increase in net income to $216 million, alongside securing a new $250 million revolving credit facility to support its global expansion and product innovation.